IPCALAB.NS
Price:
$1354.4
Market Cap:
$343.62B
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1996-01-01
Stock Exchange
NSE
Ticker
IPCALAB.NS
According to Ipca Laboratories Limited’s latest financial reports and current stock price. The company's current PE Ratio is 46.46. This represents a change of 52.13% compared to the average of 30.54 of the last 4 quarters.
The mean historical PE Ratio of Ipca Laboratories Limited over the last ten years is 36.14. The current 46.46 PE Ratio has changed 12.76% with respect to the historical average. Over the past ten years (40 quarters), IPCALAB.NS's PE Ratio was at its highest in in the March 2024 quarter at 132.09. The PE Ratio was at its lowest in in the January 2015 quarter at 0.
Average
36.14
Median
32.82
Minimum
0
Maximum
76.37
Discovering the peaks and valleys of Ipca Laboratories Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 146.64%
Maximum Annual PE Ratio = 76.37
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = 0
Year | PE Ratio | Change |
---|---|---|
2025 | 0 | -100.00% |
2024 | 57.52 | 31.88% |
2023 | 43.62 | 42.62% |
2022 | 30.58 | 44.62% |
2021 | 21.15 | -27.09% |
2020 | 29.01 | 5.00% |
2019 | 27.63 | -21.19% |
2018 | 35.05 | -13.38% |
2017 | 40.47 | -47.01% |
2016 | 76.37 | 146.64% |
The current PE Ratio of Ipca Laboratories Limited (IPCALAB.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
33.71
5-year avg
30.58
10-year avg
36.14
Ipca Laboratories Limited’s PE Ratio is greater than Alkem Laboratories Limited (26.36), less than Torrent Pharmaceuticals Limited (56.11), greater than Alembic Pharmaceuticals Limited (31.50), greater than Ajanta Pharma Limited (35.12), less than Divi's Laboratories Limited (79.87),
Company | PE Ratio | Market cap |
---|---|---|
26.36 | $570.74B | |
56.11 | $1.07T | |
31.50 | $183.73B | |
35.12 | $323.30B | |
79.87 | $1.75T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ipca Laboratories Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ipca Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ipca Laboratories Limited's PE Ratio?
How is the PE Ratio calculated for Ipca Laboratories Limited (IPCALAB.NS)?
What is the highest PE Ratio for Ipca Laboratories Limited (IPCALAB.NS)?
What is the 3-year average PE Ratio for Ipca Laboratories Limited (IPCALAB.NS)?
What is the 5-year average PE Ratio for Ipca Laboratories Limited (IPCALAB.NS)?
How does the current PE Ratio for Ipca Laboratories Limited (IPCALAB.NS) compare to its historical average?